These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16531920)

  • 1. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours.
    Jacobsson H; Wilczek B; Bergh J; von Schoultz E; Eriksson E; Larsson SA
    Nucl Med Commun; 2006 Apr; 27(4):347-52. PubMed ID: 16531920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
    Marshall C; Eremin J; El-Sheemy M; Eremin O; Griffiths PA
    Nucl Med Commun; 2005 Jan; 26(1):9-15. PubMed ID: 15604942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
    Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
    Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
    Portnoĭ SM; Odzharova AA; Shiriaev SV; Anurova OA; Laktionov KP; Riabchikov DA
    Vopr Onkol; 2006; 52(6):620-3. PubMed ID: 17338237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment of neoadjuvant chemotherapy by FEC-courses of locally advanced breast cancer using 99mTc-MIBI.
    Wilczek B; von Schoultz E; Bergh J; Eriksson E; Larsson SA; Jacobsson H
    Acta Radiol; 2003 May; 44(3):284-7. PubMed ID: 12751999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
    J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
    Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
    Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
    Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
    J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer: reply.
    Fukushima K; Ishii K; Sakai E
    Eur J Nucl Med; 1998 Jul; 25(7):816-8. PubMed ID: 9741995
    [No Abstract]   [Full Text] [Related]  

  • 17. 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.
    Danielsson R; Sánchez-Crespo A; Pegerfalk A; Grabowska H; Larsson SA; Boné B; Aspelin P
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):662-6. PubMed ID: 12616323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the accuracy of retention and washout measurements of 99mTc-Sestamibi from breast tumours using an anthropomorphic phantom.
    Marshall C; Griffiths PA
    Phys Med Biol; 2005 May; 50(9):2113-26. PubMed ID: 15843740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.
    Cwikla JB; Buscombe JR; Barlow RV; Kelleher SM; Parbhoo SP; Crow J; Deery A; Jones AL; Hilson AJ
    Eur J Nucl Med; 1997 Sep; 24(9):1175-8. PubMed ID: 9283114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
    Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
    Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.